Quality of Life Outcomes From a Randomized Phase III Trial of Cisplatin With or Without Topotecan in Advanced Carcinoma of the Cervix: A Gynecologic Oncology Group Study

Life Outcomes ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Advanced Carcinoma

Quality of Life Outcomes From a Randomized Phase III Trial of Cisplatin With or Without Topotecan in Advanced Carcinoma of the Cervix: A Gynecologic Oncology Group Study

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70098-8 ◽

2006 ◽

Vol 2006 ◽

pp. 136-137

Author(s):

J.T. Thigpen

Keyword(s):

Quality Of Life ◽

Gynecologic Oncology ◽

Phase Iii ◽

Life Outcomes ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Advanced Carcinoma

Quality-of-life results of a randomized phase III trial of four cisplatin (Cis) containing doublet combinations in stage IVB cervical carcinoma: A gynecologic oncology group (GOG) study

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.5529 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 5529-5529 ◽

Cited By ~ 5

Author(s):

L. B. Wenzel ◽

H. Huang ◽

D. Cella ◽

B. J. Monk ◽

M. W. Sill ◽

...

Keyword(s):

Quality Of Life ◽

Cervical Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Stage Ivb

Quality of Life Outcomes of a Randomized, Placebo-Controlled Trial of Bevacizumab in the Front-Line Treatment of Ovarian Cancer: a Gynecologic Oncology Group Study

European Journal of Cancer ◽

10.1016/s0959-8049(11)70122-8 ◽

2011 ◽

Vol 47 ◽

pp. 12 ◽

Cited By ~ 1

Author(s):

B.J. Monk ◽

H. Huang ◽

R.A. Burger ◽

R.L. Mannel ◽

H.D. Homesley ◽

...

Keyword(s):

Quality Of Life ◽

Controlled Trial ◽

Gynecologic Oncology ◽

Line Treatment ◽

Life Outcomes ◽

Oncology Group ◽

Front Line ◽

Effects of the WRITE Symptoms interventions on symptom and quality-of-life outcomes for women with recurrent ovarian cancer. GOG-259: An NRG Oncology/Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2017.03.073 ◽

2017 ◽

Vol 145 ◽

pp. 25-26

Author(s):

H.S. Donovan ◽

S. Sereika ◽

R.P. Edwards ◽

C.S. Bender ◽

B. Given ◽

...

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Gynecologic Oncology ◽

Recurrent Ovarian Cancer ◽

Life Outcomes ◽

Oncology Group ◽

Oncology Group Study ◽

Quality Of Life Outcomes

Faculty Opinions recommendation of Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.8972962.9534062 ◽

2011 ◽

Author(s):

Lee-May Chen

Keyword(s):

Gynecologic Oncology ◽

Low Risk ◽

Phase Iii ◽

Gestational Trophoblastic Neoplasia ◽

Oncology Group ◽

Phase Iii Trial ◽

Quality of life and survival in advanced cervical cancer: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2012.01.047 ◽

2012 ◽

Vol 125 (2) ◽

pp. 315-319 ◽

Cited By ~ 22

Author(s):

Dana M. Chase ◽

Helen Q. Huang ◽

Lari Wenzel ◽

David Cella ◽

Richard McQuellon ◽

...

Keyword(s):

Quality Of Life ◽

Cervical Cancer ◽

Gynecologic Oncology ◽

Advanced Cervical Cancer ◽

Oncology Group ◽

Quality-of-life outcomes from a randomized phase III trial of dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin as a first-line treatment for stage II–IV ovarian cancer: Japanese Gynecologic Oncology Group Trial (JGOG3016)

Annals of Oncology ◽

10.1093/annonc/mdt527 ◽

2014 ◽

Vol 25 (1) ◽

pp. 251-257 ◽

Cited By ~ 17

Author(s):

K. Harano ◽

F. Terauchi ◽

N. Katsumata ◽

F. Takahashi ◽

M. Yasuda ◽

...

Keyword(s):

Gynecologic Oncology ◽

Phase Iii ◽

Life Outcomes ◽

First Line ◽

Phase Iii Trial ◽

Dose Dense ◽

Group Trial ◽

First Line Treatment

Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: A Gynecologic Oncology Group Study

Gynecologic Oncology ◽

10.1016/j.ygyno.2005.11.013 ◽

2006 ◽

Vol 100 (1) ◽

pp. 27-32 ◽

Cited By ~ 227

Author(s):

Joan L. Walker ◽

Deborah K. Armstrong ◽

Helen Q. Huang ◽

Jeffrey Fowler ◽

Kenneth Webster ◽

...

Keyword(s):

Intraperitoneal Chemotherapy ◽

Gynecologic Oncology ◽

Phase Iii ◽

Stage Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Response to Dr. Markman's letter “Re: ‘Randomized phase III trial of three versus six cycles of carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group Study’”

Gynecologic Oncology ◽

10.1016/j.ygyno.2007.01.007 ◽

2007 ◽

Vol 105 (1) ◽

pp. 280-281

Author(s):

J BELL

Keyword(s):

Ovarian Carcinoma ◽

Early Stage ◽

Gynecologic Oncology ◽

Epithelial Ovarian Carcinoma ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

A Comparison of Quality-of-Life Domains and Clinical Factors in Ovarian Cancer Patients: A Gynecologic Oncology Group Study

Journal of Pain and Symptom Management ◽

10.1016/j.jpainsymman.2009.09.022 ◽

2010 ◽

Vol 39 (5) ◽

pp. 839-846 ◽

Cited By ~ 25

Author(s):

Vivian E. von Gruenigen ◽

Helen Q. Huang ◽

Karen M. Gil ◽

Heidi E. Gibbons ◽

Bradley J. Monk ◽

...

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Cancer Patients ◽

Gynecologic Oncology ◽

Life Domains ◽

Oncology Group ◽

Clinical Factors ◽